| P50 | author | Giuseppe Nappi | Q67218060 |
| | Federica Galli | Q42327539 |
| | Vincenzo Guidetti | Q42327541 |
| P2093 | author name string | G Sances | |
| | N Ghiotto | |
| | C Rezzani | |
| | E Guaschino | |
| P2860 | cites work | Does medication overuse headache represent a behavior of dependence? | Q51924064 |
| | Psychiatric comorbidity in the evolution from migraine to medication overuse headache. | Q51929052 |
| | Chronic daily headache in childhood and adolescence: clinical aspects and a 4-year follow-up. | Q51937312 |
| | Psychiatric comorbidity in chronic daily headache. | Q51995489 |
| | Features of medication overuse headache following overuse of different acute headache drugs. | Q53308175 |
| | Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. | Q53347246 |
| | Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache? | Q57992554 |
| | Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study | Q28294827 |
| | Rates and predictors for relapse in medication overuse headache: a 1-year prospective study | Q34200606 |
| | The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache | Q34420699 |
| | New appendix criteria open for a broader concept of chronic migraine | Q34523930 |
| | Probable medication-overuse headache: the effect of a 2-month drug-free period | Q34527544 |
| | Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). | Q34885957 |
| | Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis | Q34987144 |
| | Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management | Q35933709 |
| | Medication-overuse headache: similarities with drug addiction | Q36024350 |
| | Diaries and calendars for migraine. A review | Q36555981 |
| | Analgesic rebound headache in clinical practice: data from a physician survey | Q36803257 |
| | Medication-overuse headache: where are we now? | Q36818676 |
| | Screening and behavioral management: medication overuse headache--the complex case | Q37053922 |
| | Drug abuse in chronic headache: a clinico-epidemiologic study | Q39538705 |
| | Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse | Q40704818 |
| | Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. | Q42595721 |
| | Does chronic daily headache arise de novo in association with regular use of analgesics? | Q44326422 |
| | Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes | Q44904189 |
| | Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up | Q46987616 |
| | Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. | Q51787120 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | headache | Q86 |
| P304 | page(s) | 329-336 | |
| P577 | publication date | 2010-02-15 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). | |
| P478 | volume | 30 | |